Clinical Trials
66
Active:2
Completed:8
Trial Phases
6 Phases
Early Phase 1:3
Phase 1:2
Phase 2:6
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (40 trials with phase data)• Click on a phase to view related trials
Not Applicable
20 (50.0%)Phase 2
6 (15.0%)Phase 4
5 (12.5%)Phase 3
4 (10.0%)Early Phase 1
3 (7.5%)Phase 1
2 (5.0%)LIGHT Trial: Levothyroxine for Gestational Hypothyroidism in Recurrent Pregnancy Loss
- First Posted Date
- 2025-05-31
- Last Posted Date
- 2025-06-04
- Target Recruit Count
- 200
- Registration Number
- NCT06999278
- Locations
- 🇨🇳
Zhejiang Women's Hospital, HangZhou, Zhejiang, China
🇨🇳Zhejiang People's Hospital, Hangzhou, Zhejiang, China
Preventive Effect of Probiotics in GDM
Not Applicable
Recruiting
- Conditions
- Gestational Diabetes Mellitus (GDM)
- First Posted Date
- 2025-04-22
- Last Posted Date
- 2025-04-27
- Target Recruit Count
- 334
- Registration Number
- NCT06938464
- Locations
- 🇨🇳
Women's Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Comparative Study of Adjuvant Therapy for Postoperative Cervical Gastric-type Adenocarcinoma
Phase 3
Not yet recruiting
- Conditions
- Gastric-type Endocervical AdenocarcinomaCervical Cancer
- Interventions
- Drug: paclitaxel and platinum
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-03-17
- Target Recruit Count
- 238
- Registration Number
- NCT06870565
A Clinical Study Comparing Chemotherapy Combined with PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients with Positive Lymph Nodes After Surgery: a Multicenter Randomized Controlled Clinical Trial
Phase 2
Active, not recruiting
- Conditions
- Cervical Cancers
- Interventions
- Drug: Chemo-immunotherapyRadiation: CCRT
- First Posted Date
- 2025-03-10
- Last Posted Date
- 2025-03-10
- Target Recruit Count
- 440
- Registration Number
- NCT06866951
- Locations
- 🇨🇳
Womens' Hosptial, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH
Early Phase 1
Not yet recruiting
- Conditions
- Neonatal Hyperbilirubinemia
- First Posted Date
- 2025-02-18
- Last Posted Date
- 2025-03-20
- Target Recruit Count
- 250
- Registration Number
- NCT06832800
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
News
No news found